Understanding how external factors affect the FHIT in early inflammatory or viral infection settings and how the FHIT inactivation facilitates cancer evolution and development are important for developing suitable prophylactic and therapeutic options for different cancer types. This evidence concerns the gene FHIT and viral infectious disease.